The Harm of E-cigarettes is Lower than FDA-approved Nicotine Therapies

Jul.01.2022
The Harm of E-cigarettes is Lower than FDA-approved Nicotine Therapies
E-cigarettes are safer and more effective than FDA-approved nicotine gum and patches, according to an article by Guy Bentley.

Guy Bentley, the Consumer Freedom Director at the American Institute for Economic Research, stated on the institute's website that e-cigarettes not only have lower risks than combustible cigarettes, but are also more effective than FDA-approved nicotine gum and patches.

 

He believes that the US Food and Drug Administration acknowledged this when it authorized Vuse e-cigarettes in 2021, stating that it recognizes the role of such safer nicotine alternatives in reducing smoking. If the Juul ban is implemented, many Juul users may resort to smoking again, while some smokers who were meant to transition to Juul may continue using traditional cigarettes.

 

Bentley criticized the FDA for going against its own claim to be acting in the best interest of public health by rejecting Juul's application. A study published in the New England Journal of Medicine found that e-cigarettes are twice as effective as traditional nicotine replacement therapy. This decision also exposes a logical inconsistency in the FDA's recently announced policy to lower nicotine levels in cigarettes to non-addictive levels, as smokers may simply smoke more to compensate for the lower nicotine content.

 

Bentley stated, "The agency's promise to transition smokers to safer alternatives rings hollow by banning the most popular e-cigarettes among adults.

 

This article is a compilation of information from third-party sources. Copyright for the compiled information belongs to the original media outlets and authors.

 

This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Product | 5ml/2ml Dual Versions, Up to 45W Output: VAPORESSO Launches LUXE X3 on Official Website
Product | 5ml/2ml Dual Versions, Up to 45W Output: VAPORESSO Launches LUXE X3 on Official Website
VAPORESSO has listed the LUXE X3, a new addition to its LUXE X series, on its official website. The device features a 2,600mAh built-in battery, adjustable 5–45W output and a 0.8-inch digital display, and comes with a 5ml pod (2ml for the TPD version). The LUXE X3 has also appeared on some UK and US online retailers for pre-order, with prices below the company’s stated MSRP of $37.9.
Jan.19 by 2FIRSTS.ai
Japan Tobacco launches third limited-edition Ploom AURA color “Aqua Green,” rolling out nationwide in December
Japan Tobacco launches third limited-edition Ploom AURA color “Aqua Green,” rolling out nationwide in December
Japan Tobacco (JT) announced that its heated tobacco device Ploom AURA will introduce a new limited-edition “Aqua Green” color in December. As the third release in JT’s 2025 limited series, the model will be available through official channels from December 1 and will roll out to convenience stores and selected tobacco retailers nationwide starting December 9.
Nov.24 by 2FIRSTS.ai
Nicoventures Granted Rehearing After Philip Morris Challenge Rejected
Nicoventures Granted Rehearing After Philip Morris Challenge Rejected
Nicoventures Trading Ltd., a subsidiary of British American Tobacco (BAT), has won an appeal at the European Patent Office (EPO), convincing the appellate board that examiners had violated its right to be heard by failing to review all of its submissions.
Dec.09 by 2FIRSTS.ai
BAT Taps McLaren Title Win for Travel Retail Activation, Launches VELO “Champions’ Edition” Nicotine Pouches
BAT Taps McLaren Title Win for Travel Retail Activation, Launches VELO “Champions’ Edition” Nicotine Pouches
British American Tobacco (BAT) is leveraging McLaren F1 Team’s 2025 Constructors’ Championship win to roll out a VELO×McLaren brand activation across the travel retail market. The campaign spans major airports in Abu Dhabi, the UK, Ireland and Spain, alongside the launch of a VELO “Champions’ Edition” product.
Dec.15 by 2FIRSTS.ai
China Announces Crackdown on Illegal Nicotine Pouch Manufacturing Involving Counterfeit VELO, ZYN, and PABLO Products
China Announces Crackdown on Illegal Nicotine Pouch Manufacturing Involving Counterfeit VELO, ZYN, and PABLO Products
The case is valued at approximately 400,000 yuan, and two suspects have been taken into custody.Video footage released by authorities shows that the counterfeit products involved well-known market brands such as VELO, ZYN, and PABLO.
Dec.01
Product | ON! PLUS: Breakdown of Six FDA-PMTA-Authorized Nicotine Pouches—6/9 mg Strengths, Slim Format, and Traditional Flavours
Product | ON! PLUS: Breakdown of Six FDA-PMTA-Authorized Nicotine Pouches—6/9 mg Strengths, Slim Format, and Traditional Flavours
The U.S. FDA has added six ON!® PLUS nicotine pouch products to its list of Marketing Granted Order (MGO) authorizations. Based on 2Firsts’ review, the approved products feature a highly standardized configuration in terms of format, nicotine strength, and flavour portfolio, primarily focusing on 6 mg and 9 mg strengths and traditional variants such as mint, wintergreen, and tobacco—reflecting a clear compliance-oriented approach.
Dec.22 by 2FIRSTS.ai